Sweileh W M
College of Pharmacy, An-Najah National University, Palestine.
Int J Clin Pharmacol Ther. 2009 Jul;47(7):434-8. doi: 10.5414/cpp47434.
To determine target blood pressure attainment and to evaluate blood pressure control relative to type of therapy among diabetic hypertensive patients.
An observational retrospective study of all diabetic hypertensive patients visiting Al-Watani governmental medical center from August 01, 2006 until August 01, 2007. The blood pressure (BP) measurement made during the patient's recent visit and documented in the medical files was used in the study. Controlled BP values for hypertensive patients with diabetes mellitus were defined per JNC 7 guidelines: 130/80 mmHg or lower. Proportions of use of 5 different antihypertensive drug classes were compared between patients with controlled and uncontrolled BP.
Of the 311 patients, 79 (25.4%) had their BP controlled. No significant differences in age, gender, body weight, duration of hypertension or diabetes, renal function, average number of anti-hypertensive medications and doses of most commonly reported antihypertensive medications were found between controlled and uncontrolled BP groups. ACE-I/ARB was the most commonly used drug class in both groups. Overall, the use of ACE-I/ARB, beta-blockers, calcium channel blockers, alpha-blockers and multi drug regimens were also not significantly different between the controlled and uncontrolled groups. However, overall use of diuretics was significantly higher in controlled group than uncontrolled group (59.5% versus 45.7%, p < 0.001).
Despite the common use of ACE-I/ ARB as recommended per JNC 7th report, the majority of the patients had uncontrolled BP. Diuretics is an important drug class in attaining target BP. Use of diuretics in combination with ACE-I as well as drug compliance needs to be emphasized and encouraged.
确定糖尿病高血压患者的目标血压达标情况,并评估相对于治疗类型的血压控制情况。
对2006年8月1日至2007年8月1日期间前往瓦塔尼政府医疗中心就诊的所有糖尿病高血压患者进行观察性回顾研究。研究采用患者最近一次就诊时测量并记录在医疗档案中的血压值。根据美国国家联合委员会第7版指南定义糖尿病高血压患者的血压控制值:130/80 mmHg或更低。比较血压控制和未控制的患者使用5种不同抗高血压药物类别的比例。
在311例患者中,79例(25.4%)血压得到控制。血压控制组和未控制组在年龄、性别、体重、高血压或糖尿病病程、肾功能、抗高血压药物平均数量以及最常报告的抗高血压药物剂量方面均未发现显著差异。ACE-I/ARB是两组中最常用的药物类别。总体而言,ACE-I/ARB、β受体阻滞剂、钙通道阻滞剂、α受体阻滞剂和联合用药方案在血压控制组和未控制组之间的使用也无显著差异。然而,利尿剂在血压控制组中的总体使用率显著高于未控制组(59.5%对45.7%,p<0.001)。
尽管按照美国国家联合委员会第7次报告的建议普遍使用ACE-I/ARB,但大多数患者的血压未得到控制。利尿剂是实现目标血压的重要药物类别。需要强调并鼓励将利尿剂与ACE-I联合使用以及提高药物依从性。